Harbin based China Sky One Medical, a pharmaceutical company producing over-the-counter drugs in the China recently obtained production approval from the Chinese State Food and Drug Administration for two of its newly developed drugs.

Haikou based China Pharma Holdings,has received approval from China's State Food and Drug Administration to start clinical trials of a combination of an antibiotic with a bacterial-enzyme inhibitor.

Charles River Laboratories International has opened a 60,000 square foot preclinical facility in Shanghai to support its clients’ global drug development needs.

Sunstone (Tangshan) Pharmaceutical Co., Ltd. a wholly-owned subsidiary of BMP Sunstone Corporation, has received a production license from the Chinese State Food and Drug Administration to manufacture and market GoodBaby Multivitamin Granules in China.

Genesis Pharmaceuticals Enterprises, Inc., a pharmaceutical company in the People's Republic of China, has announced that the company has received approval from the Chinese State Food and Drug Administration to start producing and distributing Radix Isatidis Dispersible Tablets.

Benda Pharmaceutical, a China-based pharmaceutical company producing both Gendicine, the world's first commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, announced its Jiangling plant has received approval from the State Food and Drug Administration to re-initiate production of its primary product line.